Inventi Impact - Preventive & Social Medicines
(Formerly Inventi Rapid/Impact: AIDS)
-
Journal Scope:
Quarterly published in print and online ‘Inventi Rapid/Impact: Preventive & Social Medicines (Formerly Inventi Rapid/Impact: AIDS)’ publishes high quality unpublished as well as high impact pre-published research and reviews catering to the needs of researchers and professionals. This journal focuses on all the aspects related to HIV/AIDS that help in better understanding of disease and improve the quality of patient care. Articles from following areas are given special emphasis – diagnosis, epidemiology, prevention, treatment, virology & immunology of HIV/AIDS, opportunistic infections and pathogenicity. Articles from social perspective like political economy are also welcome.
-
ASSESS THE EFFECTIVENESS OF STRUCTURED TEACHING PROGRAMME ON KNOWLEDGE, ATTITUDE AND PRACTICE ON NECKLACE METHOD OF FAMILY PLANNING AMONG MOTHERS
Family planning coupled with basic health services makes appositive contribution to the health and wellbeing of mothers and children. In the reproductive age group of 15-45 years, there are 35 million people who are not using any methods of contraception. In spite of the fact that they would like to stop or space child bearing but do not have the adequate knowledge on standard days method regardin...
Read More -
POINT OF CARE TECHNOLOGIES FOR HIV
Effective prevention of HIV/AIDS requires early diagnosis, initiation of therapy, and regular plasma viral load monitoring of the infected individual. In addition, incidence estimation using accurate and sensitive assays is needed to facilitate HIV prevention efforts in the public health setting. Therefore,more affordable and accessible point-of-care (POC) technologies capable of providing earl...
Read More -
ETRAVIRINE AS A SWITCHING OPTION FOR PATIENTS WITH HIV RNA SUPPRESSION: A REVIEW OF RECENT TRIALS
Unlike other nonnucleoside reverse transcriptase inhibitors, etravirine is only approved for use in treatment-experienced patients. In the DUET 1 and 2 trials, 1203 highly treatment-experienced patients were randomized to etravirine or placebo, in combination with darunavir/ritonavir and optimized background treatment. In these trials, etravirine showed significantly higher rates of HIV RNA sup...
Read More -
ENGAGEMENT WITH CARE, SUBSTANCE USE AND ADHERENCE TO THERAPY IN HIV/AIDS
Engagement with care for those living with HIV is aimed at establishing a strong relationship between patients and their health care provider and is often associated with greater adherence to therapy and treatment (Flickinger, Saha, Moore, and Beach, 2013). Substance use behaviors are linked with lower rates of engagement with care and medication adherence (Horvath, Carrico, Simoni, Boyer, Amic...
Read More -
WILL AN UNSUPERVISED SELF-TESTING STRATEGY BE FEASIBLE TO OPERATIONALIZE IN CANADA? RESULTS FROM A PILOT STUDY IN STUDENTS OF A LARGE CANADIAN UNIVERSITY
Background. A convenient, private, and accessible HIV self-testing strategy stands to complement facility-based conventional testing. Over-the-counter oral HIV self-tests are approved and available in the United States, but not yet in Canada. Canadian data on self-testing is nonexistent.We investigated the feasibility of offering an unsupervised self-testing strategy to Canadian students. Metho...
Read More -
HIV TESTING AND COUNSELLING IN COLOMBIA: LOCAL EXPERIENCE ON TWO DIFFERENT RECRUITMENT STRATEGIES TO BETTER REACH LOW SOCIOECONOMIC STATUS COMMUNITIES
HIV testing rates remain very low in Colombia, with only 20% of individuals at risk ever tested. In order to tackle this issue, the Corporacion de Lucha Contra el Sida (CLS) has implemented a multidisciplinary, provider-initiated, population-based HIV testing/counselling strategy named BAFI. In this report, we describe the experience of CLS at reaching populations from low socioeconomic backgro...
Read More